Celltrion Healthcare Co Ltd
KOSDAQ:091990
Celltrion Healthcare Co Ltd
Cost of Revenue
Celltrion Healthcare Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
Cost of Revenue
-₩1.4T
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
C
|
Chorokbaem Healthcare Co Ltd
KRX:118000
|
Cost of Revenue
-₩48.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
W
|
WSI Co Ltd
KOSDAQ:299170
|
Cost of Revenue
-₩17.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
W
|
Wonik Co Ltd
KOSDAQ:032940
|
Cost of Revenue
-₩65.8B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-4%
|
H
|
HLB Life Science Co Ltd
KOSDAQ:067630
|
Cost of Revenue
-₩98.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-17%
|
See Also
What is Celltrion Healthcare Co Ltd's Cost of Revenue?
Cost of Revenue
-1.4T
KRW
Based on the financial report for Jun 30, 2023, Celltrion Healthcare Co Ltd's Cost of Revenue amounts to -1.4T KRW.
What is Celltrion Healthcare Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-15%
Over the last year, the Cost of Revenue growth was 3%. The average annual Cost of Revenue growth rates for Celltrion Healthcare Co Ltd have been -13% over the past three years , -15% over the past five years .